The summit will discuss the tipping points for data-driven health adoption and investment. It will look at what’s driving clinical and patient adoption of digital health technologies. It will examine the critical influences on investment and weigh-up how global trends are shaping companies.

We plan to run this as a "hybrid" event with a small number of people including speakers attending in person and others joining via zoom.Please register for your free place and we will send you your zoom login and password in advance of the event.

BioBeat20 programme

14.00-14.10 Welcomes: Miranda Weston-Smith, BioBeat Founder; Véronique Birault, Director of Translation, Francis Crick Institute.

14.10-14.40 Keynote-"Clinical adoption of innovation, opportunities, challenges and practicalities."

Samra Turajlic, Group Leader, Francis Crick Institute and Consultant, Royal Marsden Hospital

Chair: Veronique Birault, Director of Translation, Francis Crick Institute

14.40-15.30 Panel discussion: Adoption of data driven health

This panel examines the impact of data driven health on medical practices and patients’ treatment. It asks where are the significant benefits?

On the panel:

Pam Garside, Partner, Newhealth, Fellow, Cambridge Judge Business School (Chair)

Tara Donnelly, Chief Digital Officer, NHSX

Sarion Bowers, Head of Policy, Wellcome Sanger Institute

Rayna Patel, CEO and Co-founder, Vine Health

Felicity Sartain, COO and Co-founder, Closed Loop Medicine

15.30-15:45 break

15:45-16:45 Panel: Creating investment value

This panel looks inside data driven health investing and asks what are the routes for creating and maximising investment value

On the panel:

Barbara Domayne-Hayman, CBO, Autifony Therapeutics, Entrepreneur in Residence, Francis Crick Institute (Chair)

Wendy Britten, CFO, Congenica

Isabel Fox, Managing Partner, Luminous VC

Shardi Nahavandi, CEO and Co-founder, Pexxi

Heather Roxborough, Partner, Optum Ventures

16:45 Closing remarks